Measurement of Dabigatran Drug Levels to Manage Patients Taking Interacting Drugs: A Case Report

Am J Med. 2016 Oct;129(10):e247-8. doi: 10.1016/j.amjmed.2016.06.017. Epub 2016 Jul 9.

Authors

Marissa Laureano¹, Mark Crowther², John Eikelboom³, Kochawan Boonyawat⁴

Affiliations

¹ Department of Medicine, McMaster University, Hamilton, Ontario, Canada. Electronic address: marissa.laureano@medportal.ca.
² Department of Pathology and Molecular Medicine, McMaster University, Hamilton, Ontario, Canada.
³ Department of Medicine, McMaster University, Hamilton, Ontario, Canada.
⁴ Department of Medicine, McMaster University, Hamilton, Ontario, Canada; Department of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.

PMID: 27401948
DOI: 10.1016/j.amjmed.2016.06.017

No abstract available

Publication types

Case Reports

MeSH terms

Administration, Oral
Aged
Anticonvulsants / administration & dosage
Anticonvulsants / adverse effects*
Anticonvulsants / pharmacokinetics*
Antithrombins / administration & dosage
Antithrombins / adverse effects*
Antithrombins / pharmacokinetics*
Carbamazepine / administration & dosage
Carbamazepine / adverse effects*
Carbamazepine / pharmacokinetics*
Dabigatran / administration & dosage
Dabigatran / adverse effects*
Dabigatran / pharmacokinetics*
Drug Interactions
Female
Humans
Male
Middle Aged

Substances

Anticonvulsants
Antithrombins
Carbamazepine
Dabigatran